Correspondence 0001104659-24-066154 from Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260) (FBIO)
Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260)
Date: May 29, 2024 · CIK: 0001429260 · Accession: 0001104659-24-066154
AI Filing Summary & Sentiment
File numbers found in text: 333-279516
Letter
Fortress Biotech, Inc.
1111 Kane Concourse, Suite 301
Bay Harbor Islands, Florida 33154
VIA EDGAR
May 29, 2024
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Lauren Hamill
Re:
Fortress Biotech, Inc.
Registration Statement on Form S-3
File No. 333-279516
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Fortress Biotech, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) so that the Registration Statement will be declared effective as of 4:00 p.m. Eastern time, on May 30, 2024, or as soon as practicable thereafter. The Company hereby authorizes Rakesh Gopalan or David S. Wolpa, both of whom are attorneys at the Company’s outside legal counsel, Troutman Pepper Hamilton Sanders LLP, to orally modify or withdraw this request for acceleration.
Once the Registration Statement has been declared effective, please orally confirm that event with Mr. Gopalan at (704) 916-2374 or Mr. Wolpa at (704) 916-2375.
Thank you for your assistance in this matter.
Very truly yours,
Fortress Biotech, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Fortress Biotech, Inc.
1111 Kane Concourse, Suite 301
Bay Harbor Islands, Florida 33154
VIA EDGAR
May 29, 2024
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Lauren Hamill
Re:
Fortress Biotech, Inc.
Registration Statement on Form S-3
File No. 333-279516
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, Fortress Biotech, Inc. (the “Company”) hereby requests that the Securities
and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement
on Form S-3 (the “Registration Statement”) so that the Registration Statement will be declared effective as of 4:00
p.m. Eastern time, on May 30, 2024, or as soon as practicable thereafter. The Company hereby authorizes Rakesh Gopalan or David S. Wolpa,
both of whom are attorneys at the Company’s outside legal counsel, Troutman Pepper Hamilton Sanders LLP, to orally modify or withdraw
this request for acceleration.
Once the Registration Statement
has been declared effective, please orally confirm that event with Mr. Gopalan at (704) 916-2374 or Mr. Wolpa at (704) 916-2375.
Thank you for your assistance
in this matter.
Very truly yours,
Fortress Biotech, Inc.
/s/ David Jin
Name: David Jin
Title: Chief Financial Officer
cc (via email):
Rakesh Gopalan and David Wolpa, Troutman Pepper Hamilton Sanders LLP